BioMérieux announces the CE marking of TB IGRA test on VIDAS

bioMérieux announces the CE marking of TB IGRA® test on VIDAS® Marcy l’Etoile, France – March 24th, 2021 – Today marks World Tuberculosis (TB) Day and bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS® TB IGRA (Interferon-Gamma Release Assay) to diagnose latent TB infection. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download